Inspire Medical Systems Inc (INSP) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com11-05

Release Date: November 04, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Inspire Medical Systems Inc (NYSE:INSP) reported...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2481454218?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/JbreRPeNL3IbIXUtVbmWjg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/11c8b3c832d38025e4e716cc89b6a931","is_english":true,"pubTime":"2024-11-05 15:09","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2481454218","market":"us","top_or_hot":-1,"title":"Inspire Medical Systems Inc (INSP) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...","media":"GuruFocus.com","content":"<div>\n<p>Release Date: November 04, 2024\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n Positive Points \n\nInspire Medical Systems Inc (NYSE:INSP) reported...</p>\n\n<a href=\"https://finance.yahoo.com/news/inspire-medical-systems-inc-insp-070928105.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inspire Medical Systems Inc (INSP) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInspire Medical Systems Inc (INSP) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-05 15:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/inspire-medical-systems-inc-insp-070928105.html><strong>GuruFocus.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Release Date: November 04, 2024\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n Positive Points \n\nInspire Medical Systems Inc (NYSE:INSP) reported...</p>\n\n<a href=\"https://finance.yahoo.com/news/inspire-medical-systems-inc-insp-070928105.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INSP","symbol_name":"Inspire Medical Systems","start_time":0,"source_url":"https://finance.yahoo.com/news/inspire-medical-systems-inc-insp-070928105.html","article_id":"2481454218","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/JbreRPeNL3IbIXUtVbmWjg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/11c8b3c832d38025e4e716cc89b6a931"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2481454218","pubTimestamp":1730790568,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"For the complete transcript of the earnings call, please refer to the full earnings call transcript.Inspire Medical Systems Inc  reported a 33% increase in revenue for Q3 2024 compared to the same period in 2023, indicating strong business performance.The company has expanded its market presence by adding 66 new centers and 13 new U.S. sales territories, enhancing its reach and potential for growth.The company achieved a net income of $18.5 million in Q3 2024, a significant improvement from a net loss of $8.5 million in the prior year period.The company faces potential revenue headwinds in Q4 2024 due to hurricanes and an IV solution shortage, which could impact financial performance.A:  It's difficult to quantify the impact at this time, but we anticipate some revenue headwinds in Q4 due to evacuation center closures and saline shortages. We're closely monitoring the situation and working to support affected staff and centers. We expect some regional impact but are doing our best to m","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"INSP":"Inspire Medical Systems"},"translate_title":"Inspire Medical Systems Inc(INSP)2024年第三季度收益看涨期权亮点：强劲的收入增长和……","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INSP":1},"content_text":"Release Date: November 04, 2024\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n Positive Points \n\nInspire Medical Systems Inc (NYSE:INSP) reported a 33% increase in revenue for Q3 2024 compared to the same period in 2023, indicating strong business performance.\nThe company has expanded its market presence by adding 66 new centers and 13 new U.S. sales territories, enhancing its reach and potential for growth.\nInspire Medical Systems Inc (NYSE:INSP) has increased its 2024 revenue guidance to $793 to $798 million, reflecting confidence in continued growth.\nThe company achieved a net income of $18.5 million in Q3 2024, a significant improvement from a net loss of $8.5 million in the prior year period.\nInspire Medical Systems Inc (NYSE:INSP) is advancing its product development with the soft launch of the new Sleep Sync programming system and the upcoming launch of the Inspire 5 neurostimulation system, which is expected to improve patient management and reduce production costs.\n\n Negative Points \n\nThe company faces potential revenue headwinds in Q4 2024 due to hurricanes and an IV solution shortage, which could impact financial performance.\nOperating expenses increased by 10% in Q3 2024 compared to the same period in 2023, primarily due to sales organization expansion and increased corporate costs.\nThere is uncertainty regarding the impact of GLP-1 drugs on the market, which could affect the demand for Inspire therapy.\nThe company needs to navigate coding strategies for the Inspire 5 system to ensure reimbursement rates remain favorable for physicians.\nInspire Medical Systems Inc (NYSE:INSP) is still working on quantifying the impact of regional disruptions, such as hurricanes, on its operations and revenue.\n\n Q & A Highlights \n\nWarning! GuruFocus has detected 4 Warning Signs with INSP.\n\nQ: Can you discuss the sustainability and trajectory of your margins, particularly in light of the recent profitability and EPS margin upside? A: (Rick, CFO) We aim to maintain consistency and leverage across our organization, not just in DTC spending but also in R&D and sales team performance. We've shown efficiencies in DTC, allowing us to create awareness and bring patients into the system more cost-effectively. R&D expenses were reduced due to some prelaunch inventory costs in the previous year, and we expect R&D to be in the mid to high teens going forward. We anticipate continued profitability on a year-over-year basis.\nQ: How are you addressing the potential impacts of the IV fluids shortage and hurricanes on utilization and revenue? A: (Tim Herbert, CEO) It's difficult to quantify the impact at this time, but we anticipate some revenue headwinds in Q4 due to evacuation center closures and saline shortages. We're closely monitoring the situation and working to support affected staff and centers. We expect some regional impact but are doing our best to mitigate it.\nQ: What are your thoughts on the potential tailwinds from increased awareness of sleep apnea due to new technologies and GLP-1 medications? A: (Tim Herbert, CEO) Increased awareness from various technologies and GLP-1 medications will likely lead to more patients being identified with sleep-disordered breathing, including obstructive sleep apnea. We believe this will be a tailwind, and our job is to connect these patients with healthcare providers efficiently.\nQ: Can you elaborate on the coding strategies for Inspire 5 and the decision not to increase its price? A: (Tim Herbert, CEO) We're working with payers and Medicare to ensure readiness for Inspire 5's launch. The OPPS rules show a slight increase, so we decided to maintain system-level pricing consistent with Inspire 4. The elimination of the pressure sensing lead will reduce production complexity and costs, benefiting patients and physicians.\nQ: How do you view the consensus for 2025, considering factors like competition and the Inspire 5 launch? A: (Rick, CFO) It's early to comment on 2025, but we believe the current consensus is not unreasonable. We have confidence due to ongoing footprint expansion, targeted DTC investments, contributions from France, and the Inspire 5 launch. We will provide more color in our Q4 earnings call.\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.This article first appeared on \nGuruFocus.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2481454218"}